Cases & Deals

Merial obtains preliminary injunction precluding sale of generic version of Frontline® Plus

Clients Merial Limited and Merial SAS

Jones Day successfully represented Plaintiffs Merial Limited and Merial SAS against Velcera Inc. and FidoPharm Inc. securing a preliminary injunction preventing the sale and distribution of generic versions of Merial's flagship FRONTLINE® Plus flea and tick products. In the Order granting the preliminary injunction, the Court explained that the Defendants' expert, who was cross-examined by Jones Day partner J. Patrick Elsevier, Ph.D., "was effectively impeached."

Merial Limited, et al. v. Velcera, Inc., et al., Civil Action No. 3-12-cv-00075 (Judge Land), 2012 BL 171582 (M.D. Ga. June 29, 2012)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.